New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
20.39
0.07
−0.34%
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Revenue to profit Twelve months to Sep 30, 2026
Of every $100 of revenue, $7.75 was left as profit. What is an income statement?
| Revenue | 919.1 | 100.0% |
|---|---|---|
| Cost of revenue | 0.0 | 0.0% |
| Gross profit | 919.1 | 100.0% |
| Selling, general & admin | −63.2 | −6.9% |
| Other operating costs | −692.3 | −75.3% |
| Operating income | 163.6 | 17.8% |
| Other income, net | −98.6 | −10.7% |
| Income tax | −1.8 | −0.2% |
| Other items | +8.0 | 0.9% |
| Net income | 71.3 | 7.8% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $775M | $813M | $860M | $919M |
| Operating income | $257M | $257M | $157M | $164M |
| Net income | $156M | $156M | $65M | $71M |
| Net margin (right axis) | 20.1% | 19.2% | 7.6% | 7.8% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Revenue |
919.09 | 859.56 | 812.84 | 774.63 |
+8 more TTM periods Free account |
Gross Profit |
919.09 | 859.56 | 812.84 | 774.63 | |
SG&A Expenses |
63.17 | 60.15 | 55.84 | 53.71 | |
Operating Income |
163.65 | 156.75 | 256.88 | 256.55 | |
Non-operating Income/Expense |
(98.63) | (96.41) | (104.53) | (103.13) | |
Non-operating Interest Expenses |
116.29 | 116.03 | 113.80 | 112.49 | |
Investment Gain/Loss (Other) |
8.02 | 7.01 | 5.62 | 3.93 | |
| 65.02 | 60.35 | 152.35 | 153.42 | ||
Income Tax Provision |
1.77 | 2.13 | 1.95 | 1.84 | |
Income after Tax |
63.25 | 58.22 | 150.40 | 151.58 | |
Dividends (Preferred) |
(0.01) | — | — | — | |
Non-Controlling Interest |
(0.24) | (0.21) | (0.17) | (0.10) | |
Net Income Common |
71.51 | 65.44 | 156.19 | 155.61 | |
EPS (Basic) |
0.28 | 0.26 | 0.64 | 0.65 | |
EPS (Diluted) |
0.28 | 0.26 | 0.63 | 0.64 | |
Shares (Basic, Weighted) |
250.33 | 246.40 | 242.83 | 239.27 | |
Shares (Diluted, Weighted) |
253.14 | 249.07 | 246.24 | 242.32 | |
Gross Margin |
100.00% | 100.00% | 100.00% | 100.00% | |
EBIT Margin |
17.81% | 18.24% | 31.60% | 33.12% | |
EBT margin |
7.07% | 7.02% | 18.74% | 19.81% | |
Net Profit Margin |
7.78% | 7.61% | 19.21% | 20.09% | |
Free Cash Flow Margin |
(25.78%) | (32.25%) | (16.17%) | (7.38%) | |
EBITDA |
389.34 | 366.18 | 453.51 | 443.54 | |
EBIT |
163.65 | 156.75 | 256.88 | 256.55 | |
EPS (Diluted, from Cont. Ops) |
0.27 | 0.26 | 0.63 | 0.64 | |
EPS (Diluted, Consolidated) |
0.27 | 0.26 | 0.63 | 0.64 | |
EPS (Basic, Consolidated) |
0.28 | 0.26 | 0.64 | 0.64 | |
Shares (Diluted, Average) |
255.21 | 251.14 | 248.31 | 244.39 | |
EPS (Basic, from Continuous Ops) |
0.28 | 0.26 | 0.64 | 0.64 | |
Income from Continuous Operations |
71.27 | 65.23 | 156.02 | 155.51 | |
Consolidated Net Income/Loss |
71.27 | 65.23 | 156.02 | 155.51 | |
EBITDA Margin |
42.36% | 42.60% | 55.79% | 57.26% | |
Operating Cash Flow Margin |
43.58% | 43.23% | 45.11% | 45.00% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026